about
Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.Monitoring the vascular response and resistance to sunitinib in renal cell carcinoma in vivo with susceptibility contrast MRI.Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?T1 mapping in cardiac MRI.Diffusion magnetic resonance imaging: A molecular imaging tool caught between hope, hype and the real world of "personalized oncology"Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors.Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives.Data-driven mapping of hypoxia-related tumor heterogeneity using DCE-MRI and OE-MRI.Defining the biological basis of radiomic phenotypes in lung cancer.Charged-particle therapy in cancer: clinical uses and future perspectives.The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability.Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.Beyond the margins: real-time detection of cancer using targeted fluorophores.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours3D volume reconstruction from serial breast specimen radiographs for mapping between histology and 3D whole specimen imaging.Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging.Oxygen Enhanced Optoacoustic Tomography (OE-OT) Reveals Vascular Dynamics in Murine Models of Prostate Cancer.Rethinking the role of clinical imagingTargeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell Carcinoma.Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches.Non-Invasive Prostate Cancer Characterization with Diffusion-Weighted MRI: Insight from In silico Studies of a Transgenic Mouse Model.A Bayesian framework for performance assessment and comparison of imaging biomarker quantification methods.UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer.Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome.Rapid volumetric photoacoustic tomographic imaging with a Fabry-Perot ultrasound sensor depicts peripheral arteries and microvascular vasomotor responses to thermal stimuli.Large-scale DNA organization is a prognostic marker of breast cancer survival.Characterisation of fibrosis in chemically-induced rat mammary carcinomas using multi-modal endogenous contrast MRI on a 1.5T clinical platform.Data Science in Radiology: A Path Forward.Has molecular imaging delivered to drug development?Radiomics and radiogenomics for precision radiotherapy.Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.A biomimetic tumor tissue phantom for validating diffusion-weighted MRI measurements.Towards enhanced PET quantification in clinical oncology.Standardization of Small Animal Imaging-Current Status and Future Prospects.Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability.Review of quantitative multiscale imaging of breast cancer.How to perform Contrast-Enhanced Ultrasound (CEUS).
P2860
Q30491569-68AF52A7-2F57-42EF-93AC-FA6CE24D05D4Q32176092-5E9F9066-755D-45A9-A287-F2A643593A9CQ33621522-3CBC8A2C-F470-4DCF-804A-A02E351B5574Q33844044-30C044F3-EA9B-4B22-8657-80D85297D2BEQ33854846-01133921-D626-47D7-B623-AAD67EA525BDQ36368541-C6A05F01-1084-4DC3-92E3-AD99653879D4Q37729968-A03FF8E0-9C74-48B9-B97B-70ABEF7720ACQ38600887-8E234B54-8F2F-47D6-8641-B0D174D40BB6Q38668238-E7ACCD71-00D7-4288-9F90-954ECFAC5241Q38746213-98636236-6B5E-4B90-A12B-71EB789F29CBQ38816759-D094BEF0-9097-485C-A7C9-4A6E236FEFC7Q38832422-669D6854-ABBA-454E-BA5C-3E113CCCC8C0Q39091749-75663B7D-51FB-4385-BCCF-4AF55A235EA9Q39233197-D1D54E06-9C1C-4A5F-852B-B5B2B603616BQ39499557-C6362D45-2266-4030-9232-732A00AEF905Q40433675-A3DE1459-B1C5-41EE-9755-A170356DE0B7Q41423088-2C774E82-3C11-481A-9417-422511C3016DQ41455519-CDF17AB1-E9D4-42F0-BA5D-B80975FFB8C2Q41633424-67B4023D-903D-4911-AF3A-1AD1CEDDF10DQ41686682-5CB9495C-8AEF-49E0-A0A6-3D63D91BFDAAQ43376025-71011EC5-A1AA-4870-B5E3-074C52DA2D41Q45945185-8B12B6F4-E057-4A55-93A4-989A25239678Q47139773-DF34E2C2-FF98-4C46-936F-1B54E83C7AD1Q47225341-C4E5936A-869D-419C-AC76-8034116E4802Q47404572-EE06B53B-13A2-4837-83A5-D67B2A202BA8Q47562329-2761C1B3-BEE0-4486-91DF-D89C8580508DQ47581407-CEF9D798-3117-451B-834D-6E718F51C71DQ47585688-D4DF2121-83FC-4D67-AFD5-12DC43E6C52EQ47607490-FC5C7336-19CE-4AD3-B216-0DA1C4AF121DQ47621680-AE6603F3-E419-45CC-AEAB-CFAD3F15F4A0Q47646427-1E9758E8-45C0-47E0-9F96-2212311507BCQ47701839-950B423A-1F1B-438E-BFCA-F95E40AF6DAFQ47769995-74EFC3E9-C28B-4714-B33A-842600FD0494Q47790176-691F1305-D6F5-45A1-A358-40C015BE83AFQ47823973-68605D47-AFD5-4C9D-BF78-A58135A5CBBEQ47877890-E38E53E9-2EAB-41BA-B472-B9C8763940C4Q47909847-F50B5B9F-B324-4211-9355-C21CD741A1A2Q47923488-64F1977D-C5AD-487A-8F1E-6C725EBEBA4AQ48119396-98AC45BA-40B3-4FAD-BD5D-7CDC6F1DE4B9Q49165838-FC6F7E37-5BCD-4FA6-83A3-9B33CFF051AE
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Imaging biomarker roadmap for cancer studies
@ast
Imaging biomarker roadmap for cancer studies
@en
Imaging biomarker roadmap for cancer studies
@en-gb
type
label
Imaging biomarker roadmap for cancer studies
@ast
Imaging biomarker roadmap for cancer studies
@en
Imaging biomarker roadmap for cancer studies
@en-gb
prefLabel
Imaging biomarker roadmap for cancer studies
@ast
Imaging biomarker roadmap for cancer studies
@en
Imaging biomarker roadmap for cancer studies
@en-gb
P2093
P2860
P50
P921
P6366
P1154
2-s2.0-84982113402
P1476
Imaging biomarker roadmap for cancer studies
@en
P2093
Ambros J Beer
Andrew Jones
Andrew R Reynolds
Anwar R Padhani
Arvind P Pathak
Ashley M Groves
Brian F Hutton
Daniel C Sullivan
David J Hawkes
Denis Lacombe
P2860
P304
P356
10.1038/NRCLINONC.2016.162
P407
P50
P5008
P5530
P577
2016-10-11T00:00:00Z
2017-03-01T00:00:00Z
P6179
1053267137
P6366
2530952499